Joshua Rivera

Phenibut is an unapproved GABA-B receptor agonist sold online as a supplement or nootropic. Repeated use can lead to dependence, and abrupt discontinuation can cause severe withdrawal including agitation, hallucinations, delirium, and seizures.

Designer benzodiazepines are unapproved benzodiazepine-like drugs sold in illicit markets. Their uncertain potency, hidden presence in counterfeit pills, and interaction with opioids or other depressants can make them dangerous.

Bromazolam is an illicit designer benzodiazepine increasingly found in counterfeit pills and mixed-drug overdoses. It can cause profound sedation, impaired coordination, and respiratory depression, especially with opioids.

Cychlorphine is an emerging non-fentanyl synthetic opioid detected in the illicit drug supply. Its high potency, hidden presence in fentanyl mixtures or counterfeit pills, and overdose risk are raising public-health concern.

Naloxone does not reverse xylazine or medetomidine themselves, but it should still be given when an overdose may involve opioids because these sedatives are commonly mixed with fentanyl and naloxone can reverse the opioid component.

Yes. Because nitazenes are opioids, naloxone can reverse opioid overdose effects. A suspected nitazene overdose is a medical emergency, and additional naloxone doses plus emergency breathing support may be needed.

California DHCS Level-of-Care Designation is a state process that requires licensed adult residential addiction treatment facilities to demonstrate they can deliver services consistent with specified ASAM residential standards.

DHCS licensing and certification are different California regulatory pathways: residential nonmedical SUD facilities are licensed by DHCS, while outpatient alcohol and drug programs are generally certified unless an exemption applies.

Incidental Medical Services are optional DHCS-approved medical services that a licensed California residential substance use disorder facility may provide to address medical issues related to detoxification, treatment, or recovery.

The No Surprises Act protects patients from many unexpected out-of-network bills for emergency services and certain non-emergency care, and some protections can apply to behavioral health services depending on the setting.